Corrections

How the UK drug regulator became the herbalists’ marketer

BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3397 (Published 19 May 2014) Cite this as: BMJ 2014;348:g3397

In this No Holds Barred column by Margaret McCartney, she suggested in the first paragraph that the Medicines and Healthcare Products Regulatory Agency (MHRA) had approved devil’s claw, arnica flower, palmetto fruit, and feverfew for efficacy (BMJ 2014;348:g3194, doi:10.1136/bmj.g3194).

To clarify, the MHRA has granted these herbs “traditional herbal registration,” which since 2005 has enabled endorsement without any evidence of efficaciousness from clinical trials, but the MHRA says that long term uses “indicate that efficacy is at least plausible.”

Notes

Cite this as: BMJ 2014;348:g3397

View Abstract